Clinical trial
Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
NCT00002812 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00002812 |
|---|---|
| Title | Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia |
| Official title | Treatment of Patients With Acute Lymphoblastic Leukemia With Unfavorable Features: A Phase III Group-wide Study |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug, Radiation |
| Interventions | asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, doxorubicin hydrochloride, idarubicin, mercaptopurine, methotrexate, pegaspargase and 4 more |
| Enrollment | 2,078 |
| Start date | Sep 1, 1996 |
| Primary completion | Mar 1, 2006 |
| First posted | Nov 24, 2003 |
| Last update posted | Aug 26, 2013 |
| Countries | Australia, Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: